Table 1 Epithelial subtypes derived from the scRNA-seq data of four HGSOC patient.
From: ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
# | Group names | PT1 (Σ 982 cells) | PT2 (Σ 312 cells) | PT3 (Σ 817 cells) | PT4 (Σ 493 cells) |
|---|---|---|---|---|---|
Non-treated | Neoadjuvant therapy | Non-treated | Neoadjuvant therapy | ||
0 | regular epithelials | 701 (71.4%) | 222 (71.2%) | 296 (36.2%) | 410 (83.2%) |
1 | interferon-γ epithelials | 140 (14.3%) | 42 (13.5%) | 259 (31.7%) | 27 (5.5%) |
2 | highly proliferative epithelials | 100 (10.2%) | 32 (10.3%) | 249 (30.5%) | 42 (8.5%) |
3 | RGS1 epithelials | 29 (3.0%) | 12 (3.8%) | 10 (1.2%) | 5 (1.0%) |
4 | EMT epithelials | 12 (1.2%) | 4 (1.3%) | 3 (0.4%) | 9 (1.8%) |
